Clincosm LogoSign in Get a demo

refractory solid tumor

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumor Trial in Xiamen (177Lu-DOTA-EB-FAPI radionuclide therapy)

Recruiting
  • Refractory Solid Tumor
  • 177Lu-DOTA-EB-FAPI radionuclide therapy
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Jul 26, 2023

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab

Recruiting
  • Relapsed Solid Tumor
  • +5 more
  • cemiplimab (monotherapy)
  • +3 more
  • Los Angeles, California
  • +19 more
Jan 27, 2022

Refractory Solid Tumor Trial (SC-43 Oral Solution)

Withdrawn
  • Refractory Solid Tumor
  • SC-43 Oral Solution
  • (no location specified)
Oct 19, 2020

Cancer, Refractory Solid Tumor Trial in United States (Cetuximab + Irinotecan)

Completed
Has Results
  • Cancer
  • Refractory Solid Tumor
  • Cetuximab + Irinotecan
  • Phoenix, Arizona
  • +8 more
Nov 24, 2015

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Sao Paulo (Oxaliplatin)

Unknown status
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Sao Paulo, SP, Brazil
    Santa Marcelina Hospital
Mar 25, 2013